TransCode Therapeutics : Shareholder Director Nominations - Form 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | March 31, 2023
United States Liberty Square Thomasa Fitzgerald Board Of Transcode Therapeutics Inc Exchange Actas Exchange Commission
Source: marketscreener.com